KLC
ABMD

Knowledge Leaders Capital’s Abiomed Inc ABMD Stock Holding History

Knowledge Leaders Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,768
Closed -$586K – 143
2022
Q1 		$586K Hold
1,768
– – 0.42% 92
2021
Q4 		$635K Buy
1,768
+172
+11% +$58.1K 0.47% 91
2021
Q3 		$520K Buy
1,596
+19
+1% +$6.44K 0.42% 89
2021
Q2 		$492K Buy
+1,577
New +$484K 0.33% 113

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Knowledge Leaders Capital's ABMD Position: Q2 2022 in Review

Knowledge Leaders Capital sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 1,768 shares — an estimated $586K sold.

Knowledge Leaders Capital first reported a position in ABMD in Q2 2021 and held it in 4 quarters. The position peaked at $635K in Q4 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Knowledge Leaders Capital reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Knowledge Leaders Capital sold 1,768 Abiomed Inc shares in Q2 2022, an estimated $586K.
  • Knowledge Leaders Capital first reported a position in Abiomed Inc in Q2 2021 and held it in 4 quarters.
  • Knowledge Leaders Capital's Abiomed Inc position peaked at $635K in Q4 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Knowledge Leaders Capital's 13F filing for Q2 2022, filed 3 Aug 2022.